Stimwave Announces Initiation of a Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial of Wireless High Frequency Stimulation for the Treatment of Chronic Non-Specific Low Back Pain

MIAMI--(BUSINESS WIRE)--Stimwave Technologies Incorporated announces initiation of the “TsunamiTM” study, a multi-center, randomized, double-blind, placebo-controlled clinical study of its wireless high frequency stimulator.